Pharma Focus Europe
ThermoFisher Scientific - Go beyond the catalog


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

CATUG and Crystal Bio Form Strategic Partnership, Introducing 'CATUG-Crystal' Joint Lab Dedicated to Advanced Nucleic Acid Analysis Services

Friday, February 23, 2024

CATUG Inc and Crystal Bio a member of Crystal Pharmatech have recently announced a longterm strategic partnership to provide advanced nucleic acidbased drug analytical services CATUG is known for its expertise in integrated nucleic acid and drug deli...

ReAlta Life Sciences Commences Phase 2 Trial of RLS-0071 for Acute Exacerbations of Chronic Obstructive Pulmonary Disease with First Patient Dosing

Thursday, February 22, 2024

ReAlta Life Sciences Inc a biotech company specializing in midstage clinical research has initiated enrollment for a Phase clinical trial for RLS This investigational drug developed from ReAltas EPICC

Aleta Biotherapeutics and Cancer Research UK's Centre for Drug Development Initiate First Patient Dosing in ALETA-001 Phase 1/2 Clinical Trial for Relapsed/Refractory B-Cell Malignancies

Thursday, February 22, 2024

Aleta Biotherapeutics a company specializing in immunooncology with a focus on CAR TCell Engager platforms to enhance cancer therapies in collaboration with Cancer Research UKs Centre for Drug Development

Avance Clinical and Ryght Collaborate to Introduce Innovative GenAI Technologies in Clinical Research Networks

Wednesday, February 21, 2024

Ryght a trailblazer in generative artificial intelligence technology for the life science industry has unveiled a strategic collaboration with Avance Clinical the foremost specialist Australian and US

Charles River Teams Up with Pluristyx to Broaden Human Pluripotent Stem Cell Offerings

Wednesday, February 21, 2024

Charles River Laboratories International Inc has recently announced a partnership with Pluristyx Inc a leading provider in the field of tools technologies and services for cell therapy development

BioCryst Unveils ORLADEYO® (berotralstat) in Italy

Tuesday, February 20, 2024

BioCryst Pharmaceuticals Inc made an announcement today regarding the decision by the Italian Medicines Agency Agenzia Italiana del Farmaco which has completed the reimbursement process and endorsed ORLADEYO This medication is recommended for the rou...

FDA Accepts Biologics License Application for Datopotamab Deruxtecan in Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

Monday, February 19, 2024

Daiichi Sankyo and AstraZenecas Biologics License Application for datopotamab deruxtecan has been accepted in the United States for the treatment of adult patients with locally advanced or metastatic nonsquamous

Sibeprenlimab Granted Breakthrough Therapy Designation by U.S. FDA for Immunoglobulin A Nephropathy

Saturday, February 17, 2024

Otsuka Pharmaceutical Development Commercialization Inc alongside Otsuka Pharmaceutical Co Ltd and Visterra Inc a subsidiary of Otsuka have announced that the US Food and Drug Administration

Osivax Initiates First-in-Human Trial for Sarbecovirus Vaccine Candidate OVX033 with First Participant Vaccination

Friday, February 16, 2024

Osivax a company specializing in biopharmaceuticals has launched its Phase trial for OVX a broadspectrum sarbecovirus vaccine candidate The trial marks a significant step forward as the first participant receives the vaccination

AMO Pharma and Population Health Research Institute Collaborate on Tideglusib Clinical Trial for Arrhythmogenic Cardiomyopathy Treatment Efficacy Assessment

Friday, February 16, 2024

AMO Pharma Limited a leading clinicalstage biopharmaceutical company specializing in rare genetic disorders has announced a groundbreaking collaboration with the Population Health Research Institute

Latest Issue
Get instant
access to our latest e-book
Lab Indonesia 2024Sartorius Lab Balance CleaningWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies 2024Equinix accelerated medical research...World Vaccine Congress Washington 2024EUROPEAN PHARMA OUTSOURCING SUMMIT 2024Pharma 2024